Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on San Marino Tech News.
Press releases published on February 18, 2026
Feb. 18, 2026
Following a Strong Debut, Newsmatics’ Hackathon Returns with Data Analytics Competition for Students
Indeterminate
EIN Presswire
Feb. 18, 2026
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
Indeterminate
GlobeNewswire
Feb. 18, 2026
Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering
Indeterminate
GlobeNewswire
Feb. 18, 2026
XOMA Royalty to Present at Investor Conferences in March
Indeterminate
GlobeNewswire
Feb. 18, 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Feb. 18, 2026
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Feb. 18, 2026
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
CEA Industries Board Advances Plan to Revise Asset Management Deal
Indeterminate
GlobeNewswire
Feb. 18, 2026
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
Data Storage Corporation Announces 2025 CEO Bonus Award with Significant Equity Component
Indeterminate
GlobeNewswire
Feb. 18, 2026
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
ODDITY to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Indeterminate
GlobeNewswire
Feb. 18, 2026
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
Indeterminate
GlobeNewswire
Feb. 18, 2026
Eupraxia Pharmaceuticals Announces Proposed Public Offering
Indeterminate
GlobeNewswire